Larvol Delta - Biond-Biologics-to-Regain-Full-Rights-to-BND22-a-Novel-Immune-Checkpoint-Inhibitor-Targeting-the-ILT2-Receptor

BND-22 - Biond Biologics

https://www.prnewswire.com/news-releases/biond-biologics-to-regain-full-rights-to-bnd-22-a-novel-immune-checkpoint-inhibitor-targeting-the-ilt2-receptor-302389900.html

Mar 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next